JPH0692958A - 5-fluoro-1,3-dioxin-4-one derivative - Google Patents

5-fluoro-1,3-dioxin-4-one derivative

Info

Publication number
JPH0692958A
JPH0692958A JP32363491A JP32363491A JPH0692958A JP H0692958 A JPH0692958 A JP H0692958A JP 32363491 A JP32363491 A JP 32363491A JP 32363491 A JP32363491 A JP 32363491A JP H0692958 A JPH0692958 A JP H0692958A
Authority
JP
Japan
Prior art keywords
dioxin
fluoro
compound
formula
oxo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP32363491A
Other languages
Japanese (ja)
Inventor
Tomoyasu Iwaoka
友保 岩岡
Chikara Kaneko
主税 金子
Masayuki Sato
雅之 佐藤
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chugai Pharmaceutical Co Ltd
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Priority to JP32363491A priority Critical patent/JPH0692958A/en
Publication of JPH0692958A publication Critical patent/JPH0692958A/en
Pending legal-status Critical Current

Links

Landscapes

  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)

Abstract

PURPOSE:To obtain a new compound useful as an intermediate for medicines and agricultural chemicals. CONSTITUTION:The compound of formula I (R1 and R2 are 1-5C alkyl or together represent 3-6C alkylene; R3 is 1-6C alkyl, aryl or trifluoromethyl), e.g. 5-fluoro-6-methyl-4-oxo-4H-1,3-dioxin-2-spirocyclohexane. This compound of formula I is obtained by fluorinating a compound of formula II with fluorine gas, providing a difluoro derivative of formula III and then treating the resultant compound with a base such as triethylamine.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明は、新規な1,3−ジオキ
シノン誘導体に関する。さらに詳しくは、医薬および農
薬等の合成化学上のシントンとして有用な5位にフッ素
原子、6位に置換基を有する1,3−ジオキシン−4−
オン誘導体に関する。
FIELD OF THE INVENTION The present invention relates to a novel 1,3-dioxynone derivative. More specifically, 1,3-dioxin-4- having a fluorine atom at the 5-position and a substituent at the 6-position, which is useful as a synthetic chemical synthon for pharmaceuticals and agricultural chemicals, etc.
An on derivative.

【0002】[0002]

【従来の技術】1,3−ジオキシン−4−オン誘導体
は、加熱によりアシルケテンを生成する有機化学上種々
の化合物の合成に有用なシントンとなる。アシルケテン
は、医薬、農薬の中間体等として有用な化合物であり、
種々の合成に用いられている。これまでに、6位置換基
の無い5−フルオロ−1,3−ジオキシン−4−オン誘
導体は知られているが、より汎用性のある6位に置換基
を有する5−フルオロ−1,3−ジオキシン−4−オン
誘導体は、知られていない。
2. Description of the Related Art 1,3-dioxin-4-one derivatives are useful synthons for the synthesis of various compounds in organic chemistry which produce acyl ketene by heating. Acyl ketene is a compound useful as an intermediate for medicines and agricultural chemicals,
It is used in various syntheses. To date, 5-fluoro-1,3-dioxin-4-one derivatives having no 6-position substituent are known, but 5-fluoro-1,3 having a substituent at the 6-position, which is more versatile, is known. -Dioxin-4-one derivatives are unknown.

【0003】[0003]

【課題を解決するための手段】本発明は、一般式(I)The present invention has the general formula (I)

【化2】 (式中、RおよびRは、同一または異なって炭素数
1〜5のアルキル基、または、一緒になって炭素数3〜
6のアルキレン基を表す。Rは、炭素数1〜6のアル
キル基または、アリール基またはトリフルオロメチル基
を表す。)で示される、5−フルオロ−1,3−ジオキ
シン−4−オン誘導体を提供するものである。
[Chemical 2] (In the formula, R 1 and R 2 are the same or different and are an alkyl group having 1 to 5 carbon atoms, or R 1 and R 2 together are 3 to 3 carbon atoms.
6 represents an alkylene group. R 3 represents an alkyl group having 1 to 6 carbon atoms, an aryl group or a trifluoromethyl group. ), Which provides a 5-fluoro-1,3-dioxin-4-one derivative.

【0004】式(I)で示される化合物は、一般に次の
ような反応により合成することができる。
The compound represented by the formula (I) can be generally synthesized by the following reaction.

【化3】 上記式中、R、R、R、は前記と同様の意味を示
す。) 式(II)の化合物は、例えば、ケミカル アンド フ
ァーマシューティカルブレタン(Chemical a
nd Pharmaceutical Bulleti
n)第31巻第6号1896〜1901頁(1983
年)に記載の方法で合成できる。
[Chemical 3] In the above formula, R 1 , R 2 , and R 3 have the same meanings as described above. ) The compound of the formula (II) can be obtained, for example, from Chemical and Pharmaceutical Bretanes (Chemical a).
nd Pharmaceutical Bulleti
n) Vol. 31, No. 6, pp. 1896-1901 (1983)
Year)).

【0005】この反応でフッ素化に用いるフッ素ガス
は、不活性ガス、例えば窒素、アルゴン、ヘリウム等で
フッ素濃度を5〜20容量%に希釈して用いる。フッ素
化は通常フッ素に比較的不活性な溶媒中で行われる。好
ましい溶媒は、アセトニトリル、メタノール、酢酸、塩
化メチレン、クロロホルム等である。
The fluorine gas used for fluorination in this reaction is diluted with an inert gas such as nitrogen, argon or helium to a fluorine concentration of 5 to 20% by volume. Fluorination is usually carried out in a solvent which is relatively inert to fluorine. Preferred solvents are acetonitrile, methanol, acetic acid, methylene chloride, chloroform and the like.

【0006】反応温度は、一般には、−70〜0℃、好
ましくは、−40〜−10℃である。中間体であるジフ
ルオロ誘導体は単離し、あるいは単離することなく塩基
処理を行い、本発明の化合物を与える。塩基としては、
第三級アミン、例えばトリエチルアミン、N,N−ジメ
チルアミノピリジン、1,8−ジアザビシクロ[5,
4,0]ウンデカン−7−エン(DBU)、1,4−ジ
アザビシクロ[2,2,0]オクタン(DABCO)等
が好ましい。
The reaction temperature is generally -70 to 0 ° C, preferably -40 to -10 ° C. The difluoro derivative as an intermediate is isolated or treated with a base without isolation to give the compound of the present invention. As a base,
Tertiary amines such as triethylamine, N, N-dimethylaminopyridine, 1,8-diazabicyclo [5,5
4,0] undecane-7-ene (DBU), 1,4-diazabicyclo [2,2,0] octane (DABCO) and the like are preferable.

【0007】溶媒としては、塩化メチレン、クロロホル
ム、テトラヒドロフラン、アセトニトリル、トルエン等
が好ましく用いられる。反応温度は、通常0〜40℃、
好ましくは15〜35℃であり、反応時間は、通常10
〜30分である。得られた生成物は通常の方法、例え
ば、真空蒸留、再結晶等により精製することができる。
As the solvent, methylene chloride, chloroform, tetrahydrofuran, acetonitrile, toluene and the like are preferably used. The reaction temperature is usually 0 to 40 ° C,
It is preferably 15 to 35 ° C., and the reaction time is usually 10
~ 30 minutes. The obtained product can be purified by a conventional method, for example, vacuum distillation, recrystallization and the like.

【0008】以下に本発明の実施例を示すが、本発明が
これにより限定されるものではない。
Examples of the present invention will be shown below, but the present invention is not limited thereto.

【実施例】【Example】

【0009】[0009]

【実施例1】5−フルオロ−6−メチル−4−オキソ−4H−1,3
−ジオキシン−2−スピロシクロヘキサンの製法
Example 1 5-Fluoro-6-methyl-4-oxo-4H-1,3
-Process for producing dioxin-2-spirocyclohexane

【0010】6−メチル−4−オキソ−4H−1,3−
ジオキシン−2−スピロシクロヘキン910mgをアセ
トニトリル50mlに溶解して−20℃に冷却した。こ
の溶液に窒素ガスで5容量%に希釈したフッ素ガス22
40mlを通した。ついで窒素ガスを10分間通じてフ
ッ素ガスを除き、反応溶液にクロロホルム80mlを加
えた後、炭酸水素ナトリウムの飽和水溶液30mlで洗
浄した。さらに水30mlで2回洗浄し、有機層を硫酸
マグネシウム(MgSO)で乾燥後、溶媒を留去し
た。得られた残査をシリカゲルカラムクロマトグラフィ
ーに付し、ヘキサン:エーテル=10:1の混合溶媒で
溶出して5,6−ジフルオロ−6−メチル−40オキソ
−1,3−ジオキサン−2−スピロシクロヘキサン30
6mgを得た。
6-methyl-4-oxo-4H-1,3-
910 mg of dioxin-2-spirocyclohexyne was dissolved in 50 ml of acetonitrile and cooled to -20 ° C. Fluorine gas 22 diluted with this solution to 5% by volume with nitrogen gas
40 ml was passed. Then, nitrogen gas was passed through for 10 minutes to remove fluorine gas, 80 ml of chloroform was added to the reaction solution, and then washed with 30 ml of a saturated aqueous solution of sodium hydrogen carbonate. Further, the mixture was washed twice with 30 ml of water, the organic layer was dried over magnesium sulfate (MgSO 4 ), and the solvent was distilled off. The obtained residue was subjected to silica gel column chromatography, and eluted with a mixed solvent of hexane: ether = 10: 1 to elute 5,6-difluoro-6-methyl-40oxo-1,3-dioxane-2-spiro. Cyclohexane 30
6 mg was obtained.

【0011】H−NMR(CDCl)δ:1.0−
2.1(10H,m),1.72(3H,dd,J=
2,27Hz),4.87(1H,dd,J=23,4
7Hz)
1 H-NMR (CDCl 3 ) δ: 1.0-
2.1 (10H, m), 1.72 (3H, dd, J =
2,27Hz), 4.87 (1H, dd, J = 23, 4)
7Hz)

【0012】ついで得られた5,6−ジフルオロ−6−
メチル−4−オキソ−1,3−ジオキサン−2−スピロ
シクロヘキサン306mgを塩化メチレン5mlに溶解
し、室温でDBU228mgを加えて30分間撹拌し
た。つぎに反応液を水5mlで3回洗浄し、有機層をM
gSOで乾燥後溶媒を留去した。得られた残査をシリ
カゲルカラムクロマトグラフィーに付し、ヘキサン:酢
酸エチル=5:1の混合溶媒で溶出して標記化合物19
3mgを得た。
The resulting 5,6-difluoro-6-
306 mg of methyl-4-oxo-1,3-dioxane-2-spirocyclohexane was dissolved in 5 ml of methylene chloride, 228 mg of DBU was added at room temperature, and the mixture was stirred for 30 minutes. Next, the reaction solution was washed 3 times with 5 ml of water, and the organic layer was washed with M
After drying with gSO 4 , the solvent was distilled off. The obtained residue was subjected to silica gel column chromatography, and eluted with a mixed solvent of hexane: ethyl acetate = 5: 1 to give the title compound 19
3 mg was obtained.

【0013】H−NMR(CDCl)δ:1.2−
2.0(10H,m),2.07(3H,d,J=4H
z) IR(CHCl) :2960,1745,168
0,1415,1180cm−1 High−Resolution MS:C1013
FOとして計算値200.0849、実測値200.
0853
1 H-NMR (CDCl 3 ) δ: 1.2-
2.0 (10H, m), 2.07 (3H, d, J = 4H
z) IR (CHCl 3 ): 2960, 1745, 168
0,1415,1180 cm −1 High-Resolution MS: C 10 H 13
FO 3 , calculated value 200.0849, measured value 200.
0853

【0014】[0014]

【実施例2】5−フルオロ−2,2−ジメチル−6−フェニル−1,
3−ジオキシン−4−オンの製法
Example 2 5-Fluoro-2,2-dimethyl-6-phenyl-1,
Process for producing 3-dioxin-4-one

【0015】2,2−ジメチル−6−フェニル−1,3
−ジオキシン−4−オン408mgをアセトニトリル2
0mlに溶解して−30℃に冷却した。この溶液に窒素
ガスで5容量%に希釈したフッ素ガス900mlを通
じ、ついで窒素ガスを10分間通じてフッ素ガスを除去
した。反応液を室温に戻し、トリエチルアミン1.01
gを加えて30分間撹拌した。反応液に酢酸エチル20
mlを加え、飽和食塩水で3回洗浄、有機層をMgSO
で乾燥後、溶媒を留去した。得られた残査をシリカゲ
ルカラムクロマトグラフィーに付し、ヘキサン:酢酸エ
チル=10:1の混合溶媒で溶出して標記化合物168
mgを得た。エーテル−ヘキサンから再結晶して無色針
状晶を得た。
2,2-dimethyl-6-phenyl-1,3
-Dioxin-4-one 408 mg in acetonitrile 2
It was dissolved in 0 ml and cooled to -30 ° C. 900 ml of fluorine gas diluted to 5% by volume with nitrogen gas was passed through this solution, and then nitrogen gas was passed through for 10 minutes to remove the fluorine gas. The reaction solution was returned to room temperature and triethylamine 1.01 was added.
g and stirred for 30 minutes. Ethyl acetate 20 in the reaction solution
ml was added, washed three times with saturated saline, and the organic layer was MgSO 4.
After drying at 4 , the solvent was distilled off. The obtained residue was subjected to silica gel column chromatography, and eluted with a mixed solvent of hexane: ethyl acetate = 10: 1 to give the title compound 168.
mg was obtained. Recrystallization from ether-hexane gave colorless needle crystals.

【0016】融点:75−76℃ H−NMR(CDCl)δ:1.87(6H,
s),7.2−8.0(5H,m) IR(CHCl) :1740,1395,119
0 cm−1 元素分析:C1211FOとして計算値 C;6
4.86 H;4.99 実測値 C;64.90 H;5.03
Melting point: 75-76 ° C. 1 H-NMR (CDCl 3 ) δ: 1.87 (6H,
s), 7.2-8.0 (5H, m ) IR (CHCl 3): 1740,1395,119
0 cm −1 elemental analysis: calculated value as C 12 H 11 FO 3 C; 6
4.86 H; 4.99 found C; 64.90 H; 5.03

【0017】[0017]

【実施例3】5−フルオロ−4−オキソ−6−フェニル−4H−1,
3−ジオキシン−2−スピロシクロヘキサンの製法
Example 3 5-Fluoro-4-oxo-6-phenyl-4H-1,
Process for producing 3-dioxin-2-spirocyclohexane

【0017】4−オキソ−6−フェニル−4H−1,3
−ジオキシン−2−スピロシクロヘキサン610mgを
アセトニトリル25mlに溶解して−40℃に冷却し
た。この溶液に窒素ガスで5容量%に希釈したフッ素ガ
ス1120mlを通じ、ついで窒素ガスを10分間通じ
てフッ素ガスを除去した。反応液に塩化メチレンを加
え、飽和炭酸水素ナトリウム水溶液で2回洗浄後、3回
水洗した。有機層をMgSOで乾燥後、溶媒を留去
し、5,6−ジフルオロ−4−オキソー6−フェニル−
1,3−ジオキサン−2−スピロシクロヘキサン563
mgを得た。
4-oxo-6-phenyl-4H-1,3
-610 mg of dioxin-2-spirocyclohexane was dissolved in 25 ml of acetonitrile and cooled to -40 ° C. 1120 ml of fluorine gas diluted to 5% by volume with nitrogen gas was passed through this solution, and then nitrogen gas was passed through for 10 minutes to remove the fluorine gas. Methylene chloride was added to the reaction solution, which was washed twice with a saturated aqueous sodium hydrogen carbonate solution and then three times with water. The organic layer was dried over MgSO 4 , the solvent was distilled off, and 5,6-difluoro-4-oxo-6-phenyl-
1,3-dioxane-2-spirocyclohexane 563
mg was obtained.

【0018】H−NMR(CDCl)δ:1.2−
2.5(10H,m),4.98(1H,dd,J=2
3,47Hz),7.53(5H,s)
1 H-NMR (CDCl 3 ) δ: 1.2-
2.5 (10H, m), 4.98 (1H, dd, J = 2)
3,47Hz), 7.53 (5H, s)

【0019】得られた5,6−ジフルオロ−4−オキソ
−6−フェニル−1,3−ジオキサン−2,スピロシク
ロヘキサン563mgを塩化メチレン10mlに溶解し
た溶液にトリチルアミン505mgを加えて、室温で3
0分間撹拌した。実施例1と同じ処理を行い、標記化合
物399mgを得た。エーテル−ヘキサンから再結晶し
て無色針状晶を得た。融点:70.5−71.0℃
To the resulting solution of 5,6-difluoro-4-oxo-6-phenyl-1,3-dioxane-2,563 mg of spirocyclohexane dissolved in 10 ml of methylene chloride was added 505 mg of tritylamine, and the mixture was stirred at room temperature for 3 times.
Stir for 0 minutes. The same treatment as in Example 1 was carried out to obtain 399 mg of the title compound. Recrystallization from ether-hexane gave colorless needle crystals. Melting point: 70.5-71.0 ° C

【0020】H−NMR (CDCl)δ:1.2
−2.0(10H,m),7.0−8.0(5H,m) IR(CHCl) :2980,1740,139
0,1190,1040cm−1 元素分析:C1515FOとして計算値 C;6
8.69 H;5.77 実測値 C;68.45 H;5.89
1 H-NMR (CDCl 3 ) δ: 1.2
-2.0 (10H, m), 7.0-8.0 (5H, m) IR (CHCl 3): 2980,1740,139
0,1190,1040 cm −1 Elemental analysis: Calculated value as C 15 H 15 FO 3 C; 6
8.69 H; 5.77 Found C; 68.45 H; 5.89

【0021】[0021]

【実施例4】5−フルオロ−4−オキソ−6−トリフルオロメチル−
4H−1,3−ジオキシン−2−スピロシクロヘキサン
の製法
Example 4 5-Fluoro-4-oxo-6-trifluoromethyl-
4H-1,3-dioxin-2-spirocyclohexane
Manufacturing method

【0022】4−オキソ−6−トリフルオロメチル−4
H−1,3−ジオキシン−2−スピシクロヘキサン70
8mgをアセトニトリル30mlに溶解し、−35℃に
冷却した。この溶液に窒素ガスで5容量%に希釈したフ
ッ素ガス3200mlを通じ、実施例3と同様の後処
理、塩基処理を行い、標記化合物148mgを得た。
4-oxo-6-trifluoromethyl-4
H-1,3-dioxin-2-spicyclohexane 70
8 mg was melt | dissolved in 30 ml of acetonitrile, and it cooled at -35 degreeC. 3200 ml of fluorine gas diluted with nitrogen gas to 5% by volume was passed through this solution, and the same post-treatment and base treatment as in Example 3 were carried out to obtain 148 mg of the title compound.

【0023】H−NMR(CDCl)δ:1.2−
2.4(10H,m) 1R(CHCl) :2960,1770,126
5,1165cm −1 High−Resolution MS:C1010
として計算値254.0566、実測値 25
4.0591
1 H-NMR (CDCl 3 ) δ: 1.2-
2.4 (10H, m) 1R (CHCl 3 ): 2960,1770,126
5,1165 cm −1 High-Resolution MS: C 10 H 10
Calculated value 254.0566 as F 4 O 3 , measured value 25
4.0591

【0024】[0024]

【発明の効果】本発明により得られた化合物は、生理活
性が期待される種々の含フッ素複素環を高収率で与え
る。
The compound obtained according to the present invention gives various fluorine-containing heterocycles expected to have physiological activity in high yield.

【0025】[0025]

【参考例】2−ジメチルアミノ−5−フルオロ−4−オキソ−6−
フェニル−1,3−オキサジン−4−オンの製法
[Reference Example] 2-dimethylamino-5-fluoro-4-oxo-6-
Process for producing phenyl-1,3-oxazin-4-one

【0026】5−フルオロ−4−オキソ−6−フェニル
−4H−1,3−ジオキシン−2−スピロシクロヘキサ
ン44.4mgとジメチルシアナミド28mgをメシチ
レン0.5mlに溶解し、1.5時間加熱還流した。反
応液をシリカゲルカラムクロマトグラフィー(酢酸エチ
ル:エタノール=4:1)で精製して、標記化合物42
mgを得た。酢酸エチルから再結晶して無色針状晶を得
た。融点:159−160.5℃
5-Fluoro-4-oxo-6-phenyl-4H-1,3-dioxin-2-spirocyclohexane (44.4 mg) and dimethylcyanamide (28 mg) were dissolved in mesitylene (0.5 ml) and heated under reflux for 1.5 hours. . The reaction mixture was purified by silica gel column chromatography (ethyl acetate: ethanol = 4: 1) to give the title compound 42.
mg was obtained. Recrystallization from ethyl acetate gave colorless needle crystals. Melting point: 159-160.5 ° C

【0027】H NMR(CDCl)δ:3.23
(6H,s),7.2−7.9(5H,m) IR(CHCl) :1660,1595,139
0 cm−1 元素分析:C1211FNとして計算値 C;
61.53 H;4.73 N;11.96 実測値 C;61.43 H;4.75 N;11.9
1 H NMR (CDCl 3 ) δ: 3.23
(6H, s), 7.2-7.9 ( 5H, m) IR (CHCl 3): 1660,1595,139
0 cm −1 elemental analysis: calculated value as C 12 H 11 FN 2 O 2 C;
61.53 H; 4.73 N; 11.96 Found C; 61.43 H; 4.75 N; 11.9.
8

Claims (1)

【特許請求の範囲】[Claims] 【請求項1】一般式(I) 【化1】 (式中、RおよびRは、同一または異なって炭素数
1〜5のアルキル基、または、一緒になって炭素数3〜
6のアルキレン基を表す。Rは、炭素数1〜6のアル
キル基または、アリール基またはトリフルオロメチル基
を表す。)で示される、5−フルオロ−1,3−ジオキ
シン−4−オン誘導体。
1. A compound represented by the general formula (I): (In the formula, R 1 and R 2 are the same or different and are an alkyl group having 1 to 5 carbon atoms, or R 1 and R 2 together are 3 to 3 carbon atoms.
6 represents an alkylene group. R 3 represents an alkyl group having 1 to 6 carbon atoms, an aryl group or a trifluoromethyl group. ), Which is a 5-fluoro-1,3-dioxin-4-one derivative.
JP32363491A 1991-10-04 1991-10-04 5-fluoro-1,3-dioxin-4-one derivative Pending JPH0692958A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP32363491A JPH0692958A (en) 1991-10-04 1991-10-04 5-fluoro-1,3-dioxin-4-one derivative

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP32363491A JPH0692958A (en) 1991-10-04 1991-10-04 5-fluoro-1,3-dioxin-4-one derivative

Publications (1)

Publication Number Publication Date
JPH0692958A true JPH0692958A (en) 1994-04-05

Family

ID=18156918

Family Applications (1)

Application Number Title Priority Date Filing Date
JP32363491A Pending JPH0692958A (en) 1991-10-04 1991-10-04 5-fluoro-1,3-dioxin-4-one derivative

Country Status (1)

Country Link
JP (1) JPH0692958A (en)

Similar Documents

Publication Publication Date Title
JPH0737460B2 (en) Pyranoindolizine derivative and method for producing the same
JPH0529216B2 (en)
US20230416252A1 (en) Process toward the manufacture of (6r,10s)-10-{4-[5-chloro-2-(4-chloro-1h-1,2,3-triazol-1-yl)phenyl]-6-oxo-1(6h)-pyrimidinyl}- 1-(difluoromethyl)-6-methyl-1,4,7,8,9,10-hexahydro-11,15-(metheno)pyrazolo[4,3-b][1,7]diazacyclotetradecin-5(6h)-one
JPS63310882A (en) Polyoxygenated labdane derivative and manufacture
JP2005523324A (en) Compounds useful for the preparation of camptothecin derivatives
JPH0692958A (en) 5-fluoro-1,3-dioxin-4-one derivative
JPS6317077B2 (en)
JPS6236374A (en) Production of thiotetroic acid
JPH0478635B2 (en)
KR19990008411A (en) Improvement method of 4-hydroxy-2-pyrrolidone
JPH02268191A (en) Production of d-mannosamine derivative
JPH0358340B2 (en)
JP2662607B2 (en) Bicyclo [8.3.0] trideca-9,13-diene-2,7-diyne derivative
JPS63132872A (en) 4-hydroxy-2-oxo-1-pyrrolidineacetonitrile and production thereof
JP2752593B2 (en) Process for producing (-)-3 (S) -methylpyridobenzoxazinecarboxylic acid derivative and intermediate thereof
JP2651658B2 (en) 1,2,3,5-tetrahydroindolizine derivative
JPS63264448A (en) Novel beta-ketonitrile
JPS5910358B2 (en) New ergoline derivative
JPS58162585A (en) Preparation of alpha-acyl lactone
JPH0812658A (en) Production of sydnones
JPH04270244A (en) Production of beta-ketoester
FR2573764A1 (en) NOVEL IMIDAZOPYRIDAZINE DERIVATIVES, PROCESS FOR THEIR PRODUCTION AND PHARMACEUTICAL COMPOSITION CONTAINING SAME
JPH04270241A (en) Production of beta-ketoester
JPS6197251A (en) Production of 3-(2,2-diemthyl-3-alkyl-6-methylenecyclohexyl)-acarylonitrile
JPH0637431B2 (en) Method for producing bicyclo (3.3.0) octanes